Viewing Study NCT01091168


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-02-27 @ 10:32 AM
Study NCT ID: NCT01091168
Status: COMPLETED
Last Update Posted: 2019-09-16
First Post: 2010-02-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer
Sponsor: Pierre Fabre Medicament
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-07
Start Date Type: ACTUAL
Primary Completion Date: 2012-08-27
Primary Completion Date Type: ACTUAL
Completion Date: 2014-01
Completion Date Type: ACTUAL
First Submit Date: 2010-02-03
First Submit QC Date: None
Study First Post Date: 2010-03-23
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-05-27
Results First Submit QC Date: None
Results First Post Date: 2019-09-16
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-08-09
Last Update Post Date: 2019-09-16
Last Update Post Date Type: ACTUAL